Who owns 60 DEGREES PHARMACEUTICALS I?
- Ticker: SXTP
- CUSIP Number: 83006g500
Tip: Access positions for across all investors
Analyze quarterly positions in 60 Degrees Pharmaceuticals I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of 60 Degrees Pharmaceuticals I stock
Who bought or sold 60 DEGREES PHARMACEUTICALS I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Kathmere Capital Management | 265k | $467k | 83% | Jun 2026 |
|
| Citadel Advisors | 22k | $39k | 100% | Jun 2026 |
|
| XTX Topco | 18k | $31k | 100% | Jun 2026 |
|
| Kovack Advisors | 15k | $26k | 100% | Jun 2026 |
|
| Geode Capital Management | 15k | $26k | -11% | Jun 2026 |
|
| UBS Group | 14k | $24k | -57% | Jun 2026 |
|
| Barclays | 1.1k | $1.9k | -43% | Jun 2026 |
|
| Advisor Group Holdings | 25.00 | $44.000000 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $2.000000 | 100% | Mar 2026 |
|
Who sold out of 60 Degrees Pharmaceuticals I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goss Wealth Management | Mar 2026 | 50.00 | $88.000000 |
| Twin Peaks Wealth Advisors | Mar 2026 | 8.00 | $14.000000 |